Business Wire | Feb 17, 2021 01:45PM EST

Akers Biosciences Responds to Erroneous Earnings Call Press Release

Feb. 17, 2021

NEW YORK--(BUSINESS WIRE)--Feb. 17, 2021--Akers Biosciences, Inc. (the "Company") (NASDAQ: AKER) confirmed that a press release issued earlier today with respect to an earnings call by Aker ASA was issued by a company wholly unrelated to the Company. The press release was errantly issued by the newswire services under the Company's name. The Company has not scheduled any earnings calls. The Company is investigating how this error occurred and reserves all rights to pursue all appropriate remedies upon learning more about the cause of this error.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210217005868/en/

CONTACT: Investor Relations: Hayden IR Brett Mass, Managing Partner Phone: (646) 536-7331 Email: brett@haydenir.com www.haydenir.com